Tracking VNDA? Get live short interest, options flow, and signals on ORTEX.Sign up free →
VN
Vanda Pharmaceuticals Inc. (VNDA) short interest & options flow
NASDAQVanda Pharmaceuticals enters the post-Q1 stretch having just delivered a messy earnings print — but with a guidance raise that gives the bulls something to work with. The company reported Q1 EPS of -$0.82, missing the -$0.69 consensus by $0.13. Revenue of $51.7M fell short of the $55.0M estimate. Those are not trivial misses. Yet Vanda simultaneously raised full-year 2026 sales…
$4.15+1.72% 1d+6.96% 1w-9.19% 1mClose: 11 Nov 2026
- Market cap
- $251M
- Next earnings
- 10 Feb 2027
See the full picture on ORTEX →Live short interest, options flow, signals, 13F filings, and more.
Key data as of 12 Nov 2026
VNDA news and analysis
RSSNo long-form analysis yet for VNDA. Pulse alerts and the live data picture are available on ORTEX.
Open VNDA on ORTEX →Want the live picture for VNDA?
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for VNDA — free to start on ORTEX.
Sign up for free →Open VNDA on ORTEX